Acute coronary syndrome in COVID-19 patients
Acute coronary syndrome (ACS) is caused by an acute mismatch between myocardial oxygen demand and its supply. This mechanism is largely associated with the progression of coronary atherosclerosis in combination with an inflammatory response, hypoxemia, and blood procoagulation. Patients with the cor...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2021-09-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2806 |
| _version_ | 1797882419099992064 |
|---|---|
| author | M. G. Chashchin A. Yu. Gorshkov O. M. Drapkina |
| author_facet | M. G. Chashchin A. Yu. Gorshkov O. M. Drapkina |
| author_sort | M. G. Chashchin |
| collection | DOAJ |
| description | Acute coronary syndrome (ACS) is caused by an acute mismatch between myocardial oxygen demand and its supply. This mechanism is largely associated with the progression of coronary atherosclerosis in combination with an inflammatory response, hypoxemia, and blood procoagulation. Patients with the coronavirus disease 2019 (COVID-19), aggravated by cardiovascular diseases and comorbidities, are at high risk of ACS.Aim. To analyze the publications, which reflects the development of ACS in patients with COVID-19, its pathogenesis, and clinical course. Material and methods. Literature data were searched using Google Scholar, PubMed, ScienceDirect, and Cyberleninka services. The analysis included data from clinical guidelines on COVID-19, data from clinical studies, reports, and systematic reviews.Results. This literature review summarizes and systematizes the data presented in modern publications, highlights the aspects of the clinical course and pathogenetic mechanisms underlying ACS in patients with COVID-19.Conclusion. The pathogenesis of COVID-19 is inextricably associated with the widespread cytopathic effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), uncontrolled immune response that causes systemic inflammation, as well as the coagulation system activation. In patients with COVID-19, along with the atherosclerosis, these mechanisms significantly increase the risk of ACS and can worsen its in-hospital course. |
| first_indexed | 2024-04-10T03:34:27Z |
| format | Article |
| id | doaj.art-c0e21cd4f7634eadaccd309f048f5437 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:34:27Z |
| publishDate | 2021-09-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-c0e21cd4f7634eadaccd309f048f54372023-03-13T07:23:30Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252021-09-0120510.15829/1728-8800-2021-28062289Acute coronary syndrome in COVID-19 patientsM. G. Chashchin0A. Yu. Gorshkov1O. M. Drapkina2Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России (Сеченовский Университет)Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава РоссииНациональный медицинский исследовательский центр терапии и профилактической медицины Минздрава РоссииAcute coronary syndrome (ACS) is caused by an acute mismatch between myocardial oxygen demand and its supply. This mechanism is largely associated with the progression of coronary atherosclerosis in combination with an inflammatory response, hypoxemia, and blood procoagulation. Patients with the coronavirus disease 2019 (COVID-19), aggravated by cardiovascular diseases and comorbidities, are at high risk of ACS.Aim. To analyze the publications, which reflects the development of ACS in patients with COVID-19, its pathogenesis, and clinical course. Material and methods. Literature data were searched using Google Scholar, PubMed, ScienceDirect, and Cyberleninka services. The analysis included data from clinical guidelines on COVID-19, data from clinical studies, reports, and systematic reviews.Results. This literature review summarizes and systematizes the data presented in modern publications, highlights the aspects of the clinical course and pathogenetic mechanisms underlying ACS in patients with COVID-19.Conclusion. The pathogenesis of COVID-19 is inextricably associated with the widespread cytopathic effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), uncontrolled immune response that causes systemic inflammation, as well as the coagulation system activation. In patients with COVID-19, along with the atherosclerosis, these mechanisms significantly increase the risk of ACS and can worsen its in-hospital course.https://cardiovascular.elpub.ru/jour/article/view/2806covid-19острый коронарный синдроминфаркт миокарданестабильная стенокардияцитокиновый штормвирус-индуцированный эндотелиитcovid-19-ассоциированная коагулопатиятромботические осложнения |
| spellingShingle | M. G. Chashchin A. Yu. Gorshkov O. M. Drapkina Acute coronary syndrome in COVID-19 patients Кардиоваскулярная терапия и профилактика covid-19 острый коронарный синдром инфаркт миокарда нестабильная стенокардия цитокиновый шторм вирус-индуцированный эндотелиит covid-19-ассоциированная коагулопатия тромботические осложнения |
| title | Acute coronary syndrome in COVID-19 patients |
| title_full | Acute coronary syndrome in COVID-19 patients |
| title_fullStr | Acute coronary syndrome in COVID-19 patients |
| title_full_unstemmed | Acute coronary syndrome in COVID-19 patients |
| title_short | Acute coronary syndrome in COVID-19 patients |
| title_sort | acute coronary syndrome in covid 19 patients |
| topic | covid-19 острый коронарный синдром инфаркт миокарда нестабильная стенокардия цитокиновый шторм вирус-индуцированный эндотелиит covid-19-ассоциированная коагулопатия тромботические осложнения |
| url | https://cardiovascular.elpub.ru/jour/article/view/2806 |
| work_keys_str_mv | AT mgchashchin acutecoronarysyndromeincovid19patients AT ayugorshkov acutecoronarysyndromeincovid19patients AT omdrapkina acutecoronarysyndromeincovid19patients |